Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”

Abstract The 5-2-1 criteria was developed to facilitate the identification and referral of patients with Parkinson’s Disease (PD) inadequately controlled by oral medications. The criterion was not developed to screen patients with PD for device-aided therapy eligibility. The robust design and valida...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Angelo Antonini, K. Ray Chaudhuri, Josefa Domingos, Joohi Jimenez-Shahed, Jack Wright, Connie H. Yan, Ali Alobaidi, Lars Bergmann, Koray Onuk, Linda Harmer, Irene A. Malaty
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-07-01
coleção:	BMC Neurology
Assuntos:	Advanced Parkinson’s disease Device-aided therapies Patient identification 5-2-1 criteria Screening performance
Acesso em linha:	https://doi.org/10.1186/s12883-024-03691-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!